Comparative studies of the in vitro dissolution and in vivo pharmacokinetics for different formulation strategies (solid dispersion, micronization, and nanocrystals) for poorly water-soluble drugs: A case study for lacidipine

被引:24
作者
Fu, Qiang [1 ]
Li, Bo [1 ]
Zhang, Dong [1 ]
Fang, Mingming [1 ]
Shao, Jingbo [1 ]
Guo, Mengran [1 ]
Guo, Zhibin [1 ]
Li, Mo [3 ]
Sun, Jin [1 ]
Zhai, Yinglei [2 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, Shenyang 110016, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Med Devices, Shenyang 110016, Peoples R China
[3] Liaoning Inst Drug Control, Shenyang 110023, Peoples R China
关键词
Lacidipine; Nanocrystals; Micronization; Solid dispersion; Dissolution; Oral bioavailability; BIOAVAILABILITY; NANOSUSPENSION; SOLUBILITY; ABSORPTION; BEHAVIOR; RAT; DOG;
D O I
10.1016/j.colsurfb.2015.05.010
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Different formulation strategies have been proposed for poorly water-soluble drugs. The objective of this study is to give an in vitro and in vivo comparison of a solid dispersion, micronization, and nanocrystals, with lacidipine as a model substance. Micronized lacidipine was obtained by jet milling, and nanocrystals were prepared by bead milling. The d(50) for the microcrystals (11,200 nm) was about 20 times larger than that for nanocrystals (623 nm). Both colloidal dispersions maintained a crystalline state after milling. Lacipil (R), lacidipine solid dispersion, was purchased from GlaxoSmithKline. It exhibited a much higher in vitro dissolution profile than both the micronized and nanonized tablets while the micronized and nanonized tablets showed approximately a 1.30- and 2.05-fold increase in AUC(0-24h) compared with Lacipil (R), respectively. Among the three formulation approaches, Lacipil (R) (solid dispersion) exhibited highest dissolution profile, while nanocrystals produced the greatest increase in oral bioavailability. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 176
页数:6
相关论文
共 25 条
[1]   Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs [J].
De Smet, Lieselotte ;
Saerens, Lien ;
De Beer, Thomas ;
Carleer, Robert ;
Adriaensens, Peter ;
Van Bocxlaer, Jan ;
Vervaet, Chris ;
Remon, Jean Paul .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (01) :107-113
[2]   Modified β-Cyclodextrin Inclusion Complex to Improve the Physicochemical Properties of Albendazole. Complete In Vitro Evaluation and Characterization [J].
Garcia, Agustina ;
Leonardi, Dario ;
Oscar Salazar, Mario ;
Celina Lamas, Maria .
PLOS ONE, 2014, 9 (02)
[3]   Influence of ageing, grinding and preheating on the thermal behaviour of α-lactose monohydrate [J].
Garnier, S. ;
Petit, S. ;
Mallet, F. ;
Petit, M. -N. ;
Lemarchand, D. ;
Coste, S. ;
Lefebvre, J. ;
Coquerel, G. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 361 (1-2) :131-140
[4]   Development of a supercritical fluid chromatography-tandem mass spectrometry method for the determination of lacidipine in beagle dog plasma and its application to a bioavailability study [J].
Geng, Yajie ;
Zhao, Longshan ;
Zhao, Juanhang ;
Guo, Bei ;
Ma, Panqin ;
Li, Yuanyuan ;
Zhang, Tianhong .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2014, 945 :121-126
[5]   Drug/lactose co-micronization by jet milling to improve aerosolization properties of a powder for inhalation [J].
Giry, K. ;
Pean, J. M. ;
Marsas, S. ;
Rolland, H. ;
Wuthrich, P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 321 (1-2) :162-166
[6]   Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation [J].
He, ZG ;
Zhong, DF ;
Chen, XY ;
Liu, XH ;
Tang, X ;
Zhao, LM .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (04) :487-491
[7]   Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability [J].
Khadka, Prakash ;
Ro, Jieun ;
Kim, Hyeongmin ;
Kim, Iksoo ;
Kim, Jeong Tae ;
Kim, Hyunil ;
Cho, Jae Min ;
Yun, Gyiae ;
Lee, Jaehwi .
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2014, 9 (06) :304-316
[8]   LACIDIPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL IN THE TREATMENT OF HYPERTENSION [J].
LEE, CR ;
BRYSON, HM .
DRUGS, 1994, 48 (02) :274-296
[9]   Drug-like properties and the causes of poor solubility and poor permeability [J].
Lipinski, CA .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2000, 44 (01) :235-249
[10]  
Loh Z. H., 2015, ASIAN J PHARM SCI